Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates
Preprint
Abstract
Significant progress has already been made in development and testing of SARS-CoV-2 vaccines, and Phase III clinical trials have begun for 6 novel vaccine candidates to date. These Phase III trials seek to demonstrate direct benefits of a vaccine on vaccine recipients. However, vaccination is also known to bring about indirect benefits to a population through the reduction of virus circulation. The indirect effects of SARS-CoV-2 vaccination can play a key role in reducing case counts and COVID-19 deaths. To illustrate this point, we show through simulation that a vaccine with strong indirect effects has the potential to reduce SARS-CoV-2 circulation and COVID-19 deaths to a greater extent than an alternative vaccine with stronger direct effects but weaker indirect effects. Protection via indirect effects may be of particular importance in the context of this virus, because elderly individuals are at an elevated risk of death but are also less likely to be directly protected by vaccination due to immune senescence. We therefore encourage ongoing data collection and model development aimed at evaluating the indirect effects of forthcoming SARS-CoV-2 vaccines.Keywords
All Related Versions
- Published version: Nature Medicine, 27 (1), 4.
This publication has 18 references indexed in Scilit:
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)Science, 2020
- Estimates of the severity of COVID-19 diseasemedRxiv, 2020
- Projecting the transmission dynamics of SARS-CoV-2 through the post-pandemic periodmedRxiv, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- The reproductive number of COVID-19 is higher compared to SARS coronavirusJournal of Travel Medicine, 2020
- Direct and indirect effects of influenza vaccinationBMC Infectious Diseases, 2017
- Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implicationsExpert Review of Vaccines, 2014
- Optimizing Influenza Vaccine DistributionScience, 2009
- Clinical Relevance of Age-Related Immune DysfunctionClinical Infectious Diseases, 2000
- Vaccination and herd immunity to infectious diseasesNature, 1985